These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12243912)

  • 21. Should you be taking tamoxifen?
    Johns Hopkins Med Lett Health After 50; 2001 Jun; 13(4):4-5. PubMed ID: 11439691
    [No Abstract]   [Full Text] [Related]  

  • 22. Two case reports of ovarian cancer after long-term tamoxifen treatment for breast cancer.
    Ohara N; Kobayashi A
    J Obstet Gynaecol; 2002 Sep; 22(5):572-3. PubMed ID: 12521448
    [No Abstract]   [Full Text] [Related]  

  • 23. Defending data-monitoring committees.
    Lancet; 1998 Apr; 351(9110):1143. PubMed ID: 9643679
    [No Abstract]   [Full Text] [Related]  

  • 24. Leiomyoma of the breast in a 50-year-old woman receiving tamoxifen.
    Son EJ; Oh KK; Kim EK; Son HJ; Jung WH; Lee HD
    AJR Am J Roentgenol; 1998 Dec; 171(6):1684-6. PubMed ID: 9843313
    [No Abstract]   [Full Text] [Related]  

  • 25. Keeping breast cancer at bay. Women at risk are asked to weigh the pros and cons of a prevention pill.
    Brink S
    US News World Rep; 1999 May; 126(21):76. PubMed ID: 10387894
    [No Abstract]   [Full Text] [Related]  

  • 26. Breast cancer trial stopped early.
    Josefson D
    BMJ; 1998 Apr; 316(7139):1187. PubMed ID: 9583923
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemoprevention of breast cancer for women at high risk.
    Chan K; Morris GJ
    Semin Oncol; 2006 Dec; 33(6):642-6. PubMed ID: 17145342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-grade endometrial stromal sarcoma following tamoxifen treatment.
    Engin H
    Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038
    [No Abstract]   [Full Text] [Related]  

  • 29. Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure.
    Rose PG; Alvarez B; Maclennan GT
    Am J Obstet Gynecol; 2000 Aug; 183(2):507-8. PubMed ID: 10942499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer-have we been chasing the wrong target?
    Dooley WC
    J Surg Oncol; 2003 Jun; 83(2):57-60. PubMed ID: 12772194
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    Powles TJ
    J Natl Cancer Inst; 1999 Apr; 91(8):730. PubMed ID: 10218518
    [No Abstract]   [Full Text] [Related]  

  • 32. The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer.
    Kelminski A
    Hawaii Med J; 2002 Sep; 61(9):209-10. PubMed ID: 12422387
    [No Abstract]   [Full Text] [Related]  

  • 33. Tamoxifen for the prevention of breast cancer. Important questions remain unanswered, and existing trials should continue.
    Bruzzi P
    BMJ; 1998 Apr; 316(7139):1181-2. PubMed ID: 9552991
    [No Abstract]   [Full Text] [Related]  

  • 34. New drugs for breast cancer.
    Smith IE
    Lancet; 2002 Sep; 360(9335):790-2. PubMed ID: 12241842
    [No Abstract]   [Full Text] [Related]  

  • 35. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
    Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
    Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The interruption of a study following an "ad interim" analysis. The example of the NSABP-P1 study].
    Savarese A
    Suppl Tumori; 2004; 3(4):S23-4. PubMed ID: 15206204
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
    Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
    J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptance of tamoxifen chemoprevention by physicians and women at risk.
    Tchou J; Hou N; Rademaker A; Jordan VC; Morrow M
    Cancer; 2004 May; 100(9):1800-6. PubMed ID: 15112259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
    Fabian C
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.